[HTML][HTML] Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis

Y Liu, Y Zhang, G Feng, Q Niu… - Experimental and …, 2017 - spandidos-publications.com
… , no clinical trials comparing the success rate of gefitinib, erlotinib and icotinib … compare the
effectiveness and adverse effects of gefitinib, erlotinib and icotinib for the treatment of patients

[HTML][HTML] A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients

P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - journals.lww.com
Adverse drug reaction of both erlotinib (n=37) and gefitinib (n=34) … Terminology Criteria for
Adverse Events grading system. … erlotinib and gefitinib had similar effectiveness but gefitinib

[HTML][HTML] Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib

Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2019 - ncbi.nlm.nih.gov
… with more efficient management of adverse events may in part … 3 or 4 adverse events for
afatinib, gefitinib, and erlotinib were … gefitinib and erlotinib have both demonstrated efficacy for …

[HTML][HTML] Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: a meta-analysis of clinical trials of gefitinib, erlotinib, and afatinib in advanced EGFR …

PN Ding, SJ Lord, V Gebski, M Links, V Bray… - Journal of Thoracic …, 2017 - Elsevier
… be based on assessing differences in effectiveness of each … In a direct head-to-head
comparison of second- versus first-… over gefitinib but higher drug-related severe adverse events

[HTML][HTML] Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene …

P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… of the EGFR-TKIs observed in our study, the type and severity of adverse events was
similar to those described in previous clinical trials (12). For example, afatinib and …

Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: a meta‐analysis

Z Yang, A Hackshaw, Q Feng, X Fu… - … journal of cancer, 2017 - Wiley Online Library
… greater efficacy than gefitinib or erlotinib in … differences have led to the assumption that
erlotinib is more effective and at the same time associated with more adverse events than gefitinib

[HTML][HTML] Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis

W Zhang, Y Wei, D Yu, J Xu, J Peng - Medicine, 2018 - journals.lww.com
… for the selection of targeted drugs, we conducted a meta-analysis of studies to compare
the antitumor effectiveness and adverse effects (AEs) of gefitinib and erlotinib for NSCLC. …

[HTML][HTML] A retrospective comparison of the clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients with non-small cell lung cancer

A Fujiwara, M Yoshida, H Fujimoto, H Nakahara… - Oncology …, 2018 - ncbi.nlm.nih.gov
compare the effectiveness of gefitinib, erlotinib, and afatinib. We retrospectively reviewed the
records of 310 patients … frequent and milder grade of adverse effects. However, comparable …

[HTML][HTML] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

JJ Yang, Q Zhou, HH Yan, XC Zhang, HJ Chen… - British journal of …, 2017 - nature.com
… to determine whether erlotinib is superior to gefitinib in efficacy. … the incidence and severity
of adverse events (AEs), according … differences in efficacy or toxicity profile between first-line …

[HTML][HTML] Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta …

W Zhang, Y Wei, D Yu, J Xu, J Peng - BMC cancer, 2018 - Springer
… To resolve this controversy, we conducted a meta-analysis of related studies to compare the
anti-tumor efficacy and adverse effects (AEs) of gefitinib and erlotinib for treating East Asian …